Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

Annual assessment of ECG intervals in patients with myotonic dystrophy type 1 using a mobile 6‑lead ECG device: TeleCheck-DM1

AI Summary
  • mECG is feasible in DM1 patients and provides reliable PQ interval assessment versus rECG (Pearson r 0.83, ICC 0.80; mean difference -2 ms).
  • Applying an mECG PQ threshold of 175 ms achieved 95% sensitivity and could reduce DM1 outpatient visits by about 37% when used as triage.
  • QRS measurements showed systematic bias with mean difference -14 ms and are unsuitable for triage in their current form.
Summarise with AI (MRCPsych/FRANZCP)

Int J Cardiol Heart Vasc. 2026 Sep 7;66:101996. doi: 10.1016/j.ijcha.2026.101996. eCollection 2026 Oct.

ABSTRACT

BACKGROUND AND AIMS: Cardiac involvement occurs in approximately 80% of patients with myotonic dystrophy type 1 (DM1), and annual follow-up with a routine 12‑lead ECG (rECG) is recommended. We assessed a mobile 6‑lead ECG device (mECG) as a triage tool to identify DM1 patients with suspected prolonged ECG intervals, validating the feasibility and accuracy of mECG-derived PQ and QRS intervals against rECG.

METHODS: This supervised in-clinic proof-of-concept study included 50 patients with DM1 and 50 cardiology patients from the cardiology outpatient clinic. All underwent rECG and mECG during a single routine visit. Agreement was assessed using correlation, intra-class correlation coefficient (ICC), and Bland-Altman analyses.

RESULTS: Median [IQR] age was 56 [40-66] years; 45% were women. mECG-derived PQ and QRS intervals correlated moderately to strongly with rECG (Pearson’s r = 0.83 and 0.74; ICC = 0.80 and 0.74). Bland-Altman analyses showed mean differences of -2 ms (PQ) and – 14 ms (QRS). The 95%-sensitivity thresholds for detecting prolonged rECG PQ intervals was 175 ms. Consulting only DM1 patients exceeding these limits would potentially reduce hospital visits by 37%. QRS demonstrated the highest systematic bias.

CONCLUSION: mECG is feasible in patients with DM1 and provides reliable assessment of PQ intervals. Integrated into annual cardiac follow-up, it could serve as a triage tool, potentially reducing outpatient visits by 37% for DM1. This may become increasingly valuable as novel DM1 therapies expand the population requiring regular cardiac surveillance. QRS triage is unsuitable in its current form.

PMID:42740933 | PMC:PMC13572175 | DOI:10.1016/j.ijcha.2026.101996

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD